Tests
SARS-CoV-2 RNA Detection
Molecular detection of SARS-CoV-2 RNA for COVID-19 diagnosis and screening.
Loading
Loading
Search products, companies, tests, and guides — go from query to quote request in one place.
Tests
Molecular detection of SARS-CoV-2 RNA for COVID-19 diagnosis and screening.
Tests
The determination of the amount of SARS-CoV-2 RNA in a sample.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott Alinity i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
Tests
A proprietary chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The persistence of immunoglobulin class G (IgG) antibodies may identify people who have been infected in the past, recovered from the illness, and possibly developed immunity.
Tests
A chemiluminescent microparticle immunoassay (CMIA) used for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum and plasma on the Abbott ARCHITECT i system. The presence of IgM antibodies may be associated with recent infection or may assist with the evaluation of disease course.
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgA antibodies against SARS-CoV-2 using the S1 domain of the spike protein.
Tests
A proprietary enzyme-linked immunosorbent assay for semi-quantitative detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein, including the receptor binding domain (RBD).
Tests
A proprietary enzyme-linked immunosorbent assay for quantitative detection of IgG antibodies against SARS-CoV-2 using the S1 domain of the spike protein, including the receptor binding domain (RBD).
Tests
A proprietary serology assay that can be used to measure IgG antibodies against the SARS-CoV-2 nucleocapsid protein (N).
Tests
A proprietary serology assay that can be used to measure IgM antibodies against the SARS-CoV-2 nucleocapsid protein (N).
Tests
A proprietary serology assay that can be used to measure IgG antibodies against the SARS-CoV-2 S1 spike receptor-binding domain (RBD).